Translating regenerative medicine therapies in neonatal necrotizing enterocolitis

Niloofar Ganji,Brian Kalish,Martin Offringa,Bo Li,James Anderson,Sylvain Baruchel,Martin Blakely,Paolo De Coppi,Simon Eaton,Estelle Gauda,Nigel Hall,Anna Heath,Michael H. Livingston,Carol McNair,Robert Mitchell,Ketan Patel,Petros Pechlivanoglou,Hazel Pleasants-Terashita,Erin Pryor,Milica Radisic,Prakesh S. Shah,Bernard Thébaud,Kasper Wang,Augusto Zani,Agostino Pierro

DOI: https://doi.org/10.1038/s41390-024-03236-x

IF: 3.953

2024-05-29

Pediatric Research

Abstract:Pediatric Research, Published online: 28 May 2024; doi:10.1038/s41390-024-03236-x Translating regenerative medicine therapies in neonatal necrotizing enterocolitis

pediatrics

What problem does this paper attempt to address?

This paper focuses on the treatment of necrotizing enterocolitis (NEC) in newborns. NEC is a severe intestinal inflammation that can lead to intestinal necrosis and perforation, with high mortality and complications such as short bowel syndrome and neurodevelopmental disorders. Currently, there is a lack of specific therapy for NEC and primarily relies on supportive care. Researchers propose that regenerative medicine therapies, especially stem cells and their derivatives, may alleviate the multifaceted pathophysiological mechanisms of NEC through anti-inflammatory, anti-apoptotic, and intestinal repair-promoting processes. Although there have been animal experiments and in vitro studies showing the potential of stem cell therapy, clinical trials in newborns have not been conducted yet.

The main objective of the paper is to address how to successfully apply stem cell therapy to the clinical treatment of NEC, including overcoming obstacles in translational medicine such as inconsistent clinical trial frameworks, inadequate interdisciplinary collaborations, and low parental involvement. The paper introduces the "NEC-ACCELERATOR" project, which is a multidisciplinary initiative aimed at accelerating the clinical translation of stem cell therapy in NEC treatment. The project goals include systematically reviewing existing research, establishing consensus diagnostic criteria, determining the optimal timing, dosage, and mode of intervention, as well as early economic evaluation. Additionally, the paper emphasizes the importance of enhancing NICU team capacity, increasing parental involvement, stepwise resolution of recruitment challenges, developing core outcome sets, and adaptive trial designs, while discussing ethical considerations, industry partnerships, and the role of health economics.

In conclusion, the paper attempts to address how to promote the safe, effective, and timely clinical application of stem cell therapy in the treatment of necrotizing enterocolitis in newborns through a collaborative framework.